| Date Filed | Type | Description |
| 06/02/2023 |
4
| MILANO VINCENT (Director) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Granted 680 shares
@ $8.27, valued at
$5.6k
|
|
| 06/02/2023 |
4
| LEVIN ALAN G (Director) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Granted 1,360 shares
@ $8.27, valued at
$11.2k
|
|
| 06/02/2023 |
4
| HEGGIE THERESA (Director) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Granted 680 shares
@ $8.27, valued at
$5.6k
|
|
| 04/05/2023 |
4
| Thackray Helen M. (Chief R&D Officer) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Sold 7,000 shares
@ $8.29, valued at
$58k
|
|
| 03/23/2023 |
4
| Stonehouse Jon P (President & CEO) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Exercised 31,055 options to buy
@ $3.22, valued at
$100k
|
|
| 03/02/2023 |
4
| MILANO VINCENT (Director) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Granted 635 shares
@ $8.85, valued at
$5.6k
|
|
| 03/02/2023 |
4
| INGRAM ROBERT ALEXANDER (Director) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Granted 2,259 shares
@ $8.85, valued at
$20k
|
|
| 03/02/2023 |
4
| HEGGIE THERESA (Director) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Granted 635 shares
@ $8.85, valued at
$5.6k
|
|
| 03/02/2023 |
4
| LEVIN ALAN G (Director) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Granted 1,271 shares
@ $8.85, valued at
$11.2k
|
|
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/02/2022 |
4
| MILANO VINCENT (Director) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Granted 421 shares
@ $13.36, valued at
$5.6k
|
|
| 12/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/02/2022 |
4
| INGRAM ROBERT ALEXANDER (Director) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Granted 1,497 shares
@ $13.36, valued at
$20k
|
|
| 11/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/02/2022 |
4
| MILANO VINCENT (Director) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Granted 404 shares
@ $13.9, valued at
$5.6k
|
|
| 09/02/2022 |
4
| LEVIN ALAN G (Director) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Granted 809 shares
@ $13.9, valued at
$11.2k
|
|
| 09/02/2022 |
4
| INGRAM ROBERT ALEXANDER (Director) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Granted 1,438 shares
@ $13.9, valued at
$20k
|
|
| 09/02/2022 |
4
| HEGGIE THERESA (Director) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Granted 404 shares
@ $13.9, valued at
$5.6k
|
|
|